Eyenovia Balance Sheet Health

Financial Health criteria checks 5/6

Eyenovia has a total shareholder equity of $9.0M and total debt of $14.3M, which brings its debt-to-equity ratio to 158.8%. Its total assets and total liabilities are $28.8M and $19.8M respectively.

Key information

158.8%

Debt to equity ratio

US$14.29m

Debt

Interest coverage ration/a
CashUS$14.85m
EquityUS$9.00m
Total liabilitiesUS$19.78m
Total assetsUS$28.78m

Recent financial health updates

Recent updates

Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?

Jan 30
Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?

Is Eyenovia (NASDAQ:EYEN) Using Debt In A Risky Way?

Oct 14
Is Eyenovia (NASDAQ:EYEN) Using Debt In A Risky Way?

Is Eyenovia (NASDAQ:EYEN) Using Debt Sensibly?

Jun 27
Is Eyenovia (NASDAQ:EYEN) Using Debt Sensibly?

Does Eyenovia (NASDAQ:EYEN) Have A Healthy Balance Sheet?

Oct 25
Does Eyenovia (NASDAQ:EYEN) Have A Healthy Balance Sheet?

Eyenovia gains as H.C. Wainwright initiates with Buy on pipeline potential

Oct 05

Eyenovia names Michael Rowe as new CEO

Jul 27

New Forecasts: Here's What One Analyst Thinks The Future Holds For Eyenovia, Inc. (NASDAQ:EYEN)

Apr 03
New Forecasts: Here's What One Analyst Thinks The Future Holds For Eyenovia, Inc. (NASDAQ:EYEN)

Earnings Beat: Eyenovia, Inc. (NASDAQ:EYEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Mar 31
Earnings Beat: Eyenovia, Inc. (NASDAQ:EYEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Eyenovia: I Can See You Better - Now

Mar 04

Eyenovia: Reassessing After The FDA Moves The Goalposts

Nov 23

Eyenovia: FDA Setback Is Big Opportunity For Investors

Nov 08

Eyenovia: Can You See Me Now?

Oct 21

Is Eyenovia (NASDAQ:EYEN) A Risky Investment?

Sep 16
Is Eyenovia (NASDAQ:EYEN) A Risky Investment?

Eyenovia updates on late-stage program for presbyopia therapy

Jun 15

Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation

Jun 02

Eyenovia announces new $25M credit facility with Silicon Valley Bank

May 10

Stuart Grant Just Bought A Sprinkling of Shares In Eyenovia, Inc. (NASDAQ:EYEN)

Mar 09
Stuart Grant Just Bought A Sprinkling of Shares In Eyenovia, Inc. (NASDAQ:EYEN)

Financial Position Analysis

Short Term Liabilities: EYEN's short term assets ($20.7M) exceed its short term liabilities ($9.5M).

Long Term Liabilities: EYEN's short term assets ($20.7M) exceed its long term liabilities ($10.2M).


Debt to Equity History and Analysis

Debt Level: EYEN has more cash than its total debt.

Reducing Debt: EYEN's debt to equity ratio has increased from 0% to 158.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EYEN has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: EYEN is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.